Six-month multi-center study comparing nabumetone with naproxen in the treatment of osteoarthritis.

[1]  C. Hawkey,et al.  Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? , 1985, Gastroenterology.

[2]  H. Jasin.  Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. , 1985, Arthritis and rheumatism.

[3]  D. Dierdorf,et al.  Nabumetone--a novel anti-inflammatory drug: bioavailability after different dosage regimens. , 1984, International journal of clinical pharmacology, therapy, and toxicology.

[4]  R. Haddock,et al.  Metabolism of nabumetone (BRL 14777) by various species including man. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  D M Clive,et al.  Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.

[6]  H. Burry,et al.  Nabumetone, a new non-steroidal anti-inflammatory drug: a comparison with naproxen. , 1983, The New Zealand medical journal.

[7]  R. Haddock,et al.  Penetration of nabumetone into inflammatory exudates in the rat , 1983, The Journal of pharmacy and pharmacology.

[8]  M. Thomson,et al.  Nabumetone (BRL 14777, 4‐[6‐methoxy‐2‐naphthyl]‐butan‐2‐one): a new anti‐inflammatory agent , 1982, The Journal of pharmacy and pharmacology.

[9]  F. Mangan,et al.  The effect of a novel, non‐steroidal anti‐inflammatory compound, nabumetone (BRL 14777), on cellular infiltration into 24‐hour polyvinyl sponge implants in the rat, compared with some steroidal and nonsteroidal anti‐inflammatory drugs , 1982, The Journal of pharmacy and pharmacology.

[10]  D. Watkins,et al.  A study of the effects of nabumetone (BRL 14777), a novel anti‐inflammatory drug, on cell infiltration into sterile cotton pellets implanted in rats , 1982, The Journal of pharmacy and pharmacology.

[11]  B. Nunn,et al.  Effect of nabumetone (BRL 14777), a new anti‐inflammatory drug, on human platelet reactivity ex vivo: comparison with naproxen , 1982, The Journal of pharmacy and pharmacology.

[12]  G. Fostiropoulos,et al.  A Comparative Study of the Effectiveness and Safety of Two Non-Steroidal Anti-Inflammatory Agents, Nabumetone and Naproxen in Rheumatoid Arthritis , 1982, The Journal of international medical research.

[13]  L. Verbruggen,et al.  Double-Blind Crossover Study of Nabumetone versus Naproxen in the Treatment of Osteoarthritis , 1982, The Journal of international medical research.

[14]  F. Ginsberg,et al.  Double-Blind Crossover Study of Nabumetone versus Naproxen in the Treatment of Osteoarthritis of the Knee and Hip , 1982, The Journal of international medical research.

[15]  D. Goldenberg,et al.  Inflammatory synovitis in degenerative joint disease. , 1982, The Journal of rheumatology.

[16]  E. Huskisson,et al.  Another look at osteoarthritis. , 1979, Annals of the rheumatic diseases.

[17]  R. Moskowitz.  Management of osteoarthritis. , 1979, Bulletin on the rheumatic diseases.

[18]  L. Gaster,et al.  4-(6-Methoxy-2-naphthyl)butan-2-one and related analogues, a novel structural class of antiinflammatory compounds. , 1978, Journal of medicinal chemistry.

[19]  G. Ehrlich.  Osteoarthritis beginning with inflammation. Definitions and correlations. , 1975, JAMA.

[20]  E. Pisko,et al.  A 6-month, double-blind study comparing nabumetone to naproxen in the treatment of osteoarthritis. , 1987, Pharmatherapeutica.

[21]  William N. Kelley,et al.  Textbook of rheumatology , 1985 .

[22]  R. Grahame,et al.  Nabumetone: a double-blind study in osteoarthrosis. , 1984, Pharmatherapeutica.